Aarti Drugs Limited (BOM:524348)

Aarti Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	33,879	31,240	39,886	31,280	39,725	64,755
Market Cap Growth	-8.12%	-21.68%	27.51%	-21.26%	-38.65%	449.47%
Enterprise Value	39,372	36,849	45,531	36,863	44,228	67,914
Last Close Price	371.20	339.80	432.83	336.36	426.08	688.75
PE Ratio	16.73	18.58	23.27	18.81	19.38	23.09
Forward PE	16.61	16.62	17.30	14.25	13.79	18.31
PS Ratio	1.34	1.31	1.58	1.15	1.60	3.01
PB Ratio	2.31	2.28	3.11	2.62	3.83	7.09
P/TBV Ratio	2.32	2.39	3.20	2.68	3.83	7.09
P/FCF Ratio	-	46.33	30.08	-	-	97.06
P/OCF Ratio	-	12.77	11.11	23.46	56.42	41.79
PEG Ratio	0.72	1.44	1.44	1.44	1.53	0.39
EV/Sales Ratio	1.56	1.54	1.80	1.36	1.78	3.15
EV/EBITDA Ratio	13.12	12.96	14.50	12.17	13.19	15.67
EV/EBIT Ratio	16.21	15.93	17.18	14.44	15.34	17.50
EV/FCF Ratio	-	54.65	34.34	-	-	101.79
Debt / Equity Ratio	0.39	0.45	0.44	0.51	0.52	0.38
Debt / EBITDA Ratio	1.91	2.15	1.79	1.99	1.60	0.80
Debt / FCF Ratio	-	9.12	4.26	-	-	5.26
Asset Turnover	-	0.95	1.04	1.17	1.25	1.29
Inventory Turnover	-	3.26	3.39	3.67	3.62	3.60
Quick Ratio	-	0.95	0.92	0.94	0.84	0.97
Current Ratio	-	1.60	1.66	1.57	1.48	1.78
Return on Equity (ROE)	-	12.68%	13.87%	14.93%	21.03%	35.81%
Return on Assets (ROA)	-	5.77%	6.83%	6.89%	9.07%	14.52%
Return on Invested Capital (ROIC)	11.51%	9.69%	10.71%	11.39%	15.72%	26.05%
Return on Capital Employed (ROCE)	-	13.30%	16.20%	17.30%	22.70%	33.20%
Earnings Yield	5.98%	5.38%	4.30%	5.32%	5.16%	4.33%
FCF Yield	-	2.16%	3.32%	-1.01%	-2.05%	1.03%
Dividend Yield	0.53%	0.29%	0.23%	0.30%	0.24%	0.36%
Payout Ratio	-	5.39%	5.41%	5.65%	4.64%	8.28%
Buyback Yield / Dilution	0.18%	0.72%	0.72%	-	0.64%	-
Total Shareholder Return	0.71%	1.02%	0.95%	0.30%	0.88%	0.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.